VALN – valneva se - american depositary shares (US:NASDAQ)
Stock Stats
News
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate [Yahoo! Finance]
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F [Yahoo! Finance]
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
Valneva SE (NASDAQ: VALN) had its price target lowered by analysts at Guggenheim from $18.00 to $17.00. They now have a "buy" rating on the stock.
Form 6-K Valneva SE For: Mar 26
Form 20-F Valneva SE For: Dec 31
Form 6-K Valneva SE For: Mar 21
Form 6-K Valneva SE For: Mar 20
Form 6-K Valneva SE For: Mar 18
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.